<DOC>
	<DOCNO>NCT00856505</DOCNO>
	<brief_summary>In stem cell transplantation treatment malignant disease , calcineurin inhibitor like cyclosporine A commonly use prevent tissue destruction ( GvHD ) activate donor immune cell . The hypothesis study , replace calcineurin inhibitor everolimus mycophenolate GvHD prophylaxis reduces toxicity treatment also improve tolerance induction donor T cell toward host , eventually increase safety stem cell transplantation .</brief_summary>
	<brief_title>Safety Study Calcineurin Inhibitor Free GvHD Prophylaxis Allogeneic Stem Cell Transplantation</brief_title>
	<detailed_description />
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Calcineurin Inhibitors</mesh_term>
	<criteria>Diagnosis hematologic malignancy , indicate allogeneic stem cell transplantation : acute myeloid leukemia ( AML ) , CR1 , ≥ CR2 , primary refractory , relapse chronic myeloid leukemia ( CML ) , chronic phase , acceleration blast crisis myelodysplastic syndrome ( MDS ) , RA/RARS ( transfusion dependent ) , RAEB , RAEBt CMML Lymphoma : plasmocytoma immunocytoma ( M. Waldenström ) chroniclymphatic leukemia ( CLL ) additional low high grade NonHodgkin Lymphoma Hodgkins disease HLAmatched ( HLAA , B , DRB1 ) relate unrelated donor available Signed informed consent CNS involvement underlie disease Pulmonary disease VC &lt; 55 % , DLCO &lt; 40 % Cardiac ejection fraction &lt; 30 % , uncontrollable arrhythmia Creatinin &gt; 1,5 mg/dl CreatininClearance &lt; 30 ml/min Bilirubin &gt; 2 mg/dl Active Hepatitis B C HIV serologic positive Pregnancy lactation Premenstrual woman without medical safe contraception Participation another clinical trial 30 day start study clinical trial interfere outcome measure . Known allergy study medication ingredient formulation Drug alcohol abuse Noncompliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Hematopoietic Stem Cell Transplantation</keyword>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Immunosuppression</keyword>
</DOC>